Doylestown Health is consistent with the COVID-19 recommendations of the Centers for Disease Control (CDC)

Doylestown Health supports continued proactive efforts to prevent an uncontrolled outbreak among our most vulnerable populations, including unvaccinated adults as well as children who are ineligible for vaccination at this time.

For more Doylestown Health COVID-19 information, visit our COVID-19 Update page.

Clinical Trials

Microscope with laboratory glassware

Gastroenterology Clinical Trials

Doylestown Health's gastroenterology team participates in clinical trials and research to help shape the way gastrointestinal disease is treated.

Active Trials: Open to Enrollment

Non-alcoholic Stearotic Hepatitis (NASH, fatty liver) - REGENERATE (NASH)

  • Evaluating the impact on NASH with fibrosis of obeticholic acid treatment
  • Coordinated by the Doylestown Health Medical Research Department: 215.345.2119

Active Trials: Not Accepting New Patients

Moderate to severe Ulcerative Colitis - UNIFI

  • Evaluating the safety and efficacy of ustekinumab induction and maintenance therapy in participants with moderately to severely active ulcerative colitis
  • Enrolled patients in follow up through February 2020

For more information about Doylestown Health's open trials, visit the U.S. National Institutes of Health's Clinical Trials database.

Blog Posts

View All Articles

Upcoming Classes and Events

Find a doctor or request an appointment.